Hosseini, K., Gollamudi, S., Reiser, H., Walters, T., & Lindstrom, R. L. (2023). 0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects. Clinical ophthalmology (Auckland, N.Z.), 17, 2219-2230. https://doi.org/10.2147/OPTH.S419857
Chicago Style (17th ed.) CitationHosseini, Kamran, Subba Gollamudi, Harvey Reiser, Tom Walters, and Richard L. Lindstrom. "0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects." Clinical Ophthalmology (Auckland, N.Z.) 17 (2023): 2219-2230. https://doi.org/10.2147/OPTH.S419857.
MLA (9th ed.) CitationHosseini, Kamran, et al. "0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects." Clinical Ophthalmology (Auckland, N.Z.), vol. 17, 2023, pp. 2219-2230, https://doi.org/10.2147/OPTH.S419857.